Symptom cluster related to fatigue in patients undergoing chemotherapy for lung cancer
Conditions
Interventions
control group:usual care
Experimental group:Intervention Program for Fatigue-related Symptoms in Patients with Lung Cancer Undergoing Chemotherapy
Sponsors
Henan Provincial People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years old; 2. Diagnosed as primary non-small cell lung cancer through pathological and cytological examinations, and the condition is stable; 3. Undergoing chemotherapy; 4. Clear consciousness, capable of independent communication Force; 5. There were at least 2 symptoms related to fatigue (assessed using the NRS scale and with a score of = 2, indicating that the patients reported experiencing fatigue or sleep disorders in the past week); 6. All participants voluntarily participated in this study.
Exclusion criteria
Exclusion criteria: 1. Recurrence of lung cancer or distant organ metastasis; 2. Concurrent with other treatment modalities such as radiotherapy, immunotherapy, and targeted therapy; 3. Concurrent with various serious diseases of important organs; 4. Currently participating in other similar studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numerical Rating Scale, NRS;Chinese version Brief Fatigue Inventory, BFI-C;Pittsburgh Sleep Quality Index, PSQI; | — |
Secondary
| Measure | Time frame |
|---|---|
| Strategies Used by People to Pro-mote Health, SU PHH;Functional Assessment of Cancer Therapy- Lung, FACT-L; | — |
Countries
China
Contacts
Public ContactCang Shundong
Henan Provincial People's Hospital
Outcome results
None listed